{
  "resourceType": "PlanDefinition",
  "id": "va-ckd-recommendations",
  "url": "http://hl7.org/fhir/uv/cpg/PlanDefinition/va-ckd-recommendations",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition"
    ]
  },
  "identifier": [
    {
      "use": "official",
      "value": "VA_CKD_Recommendations"
    }
  ],
  "version": "0.1.0",
  "name": "VA_CKD_Recommendations",
  "title": "VA CKD Recommendations",
  "description": "VA CKD Recommendations",
  "type": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
        "code": "eca-rule",
        "display": "ECA Rule"
      }
    ]
  },
  "useContext": [
    {
      "code": {
        "system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
        "code": "focus",
        "display": "Clinical Focus"
      },
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "709044004",
            "display": "Chronic kidney disease (disorder)"
          }
        ]
      }
    }
  ],
  "topic": [
    {
      "coding": [
        {
          "system": "http://terminology.hl7.org/CodeSystem/definition-topic",
          "code": "treatment",
          "display": "Treatment"
        }
      ]
    }
  ],
  "status": "draft",
  "experimental" : true,
  "date": "2019-07-28T00:00:00+00:00",
  "approvalDate": "2019-07-28",
  "lastReviewDate": "2019-07-28",
  "effectivePeriod": {
    "start": "2019-07-28"
  },
  "publisher": "HL7 FHIR Clinical Guidelines Example Artifact",
  "copyright" : "Copyright Â© Example.org 2019.",
  "author": [
    {
      "name": "Dave Carlson"
    }
  ],
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US",
          "display": "United States of America"
        }
      ]
    }
  ],
  "library": [
    "Library/va-ckd-guideline"
  ],
  "action": [
    {
      "id": "001",
      "title": "CKD Protein Diet",
      "description": "In patients with stage 3 and 4 CKD, we suggest a protein diet of 0.6 to 0.8 g/kg/day as it may slow the decline in glomerular filtration rate (GFR) and progression to end-stage renal disease (ESRD).",
      "documentation": [
        {
          "extension": [
            {
              "url": "http://hl7.org/fhir/StructureDefinition/cqf-strengthOfRecommendation",
              "valueCodeableConcept": {
                "coding": [
                  {
                    "system": "http://terminology.hl7.org/CodeSystem/recommendation-strength",
                    "code": "weak",
                    "display": "Weak"
                  }
                ]
              }
            },
            {
              "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-directionOfRecommendation",
              "valueCodeableConcept": {
                "coding": [
                  {
                    "system": "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-recommendation-direction",
                    "code": "for",
                    "display": "For"
                  }
                ]
              }
            }
          ],
          "type": "documentation",
          "display": "VA/DoD Clinical Practice Guideline for The management of Chronic Kidney Disease in Primary care",
          "url": "http://www.healthquality.va.gov"
        }
      ],
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "language": "text/cql",
            "expression": "Has CKD stage 3 or 4"
          }
        }
      ]
    }
  ]
}
